SCHEMBL4515950

SCHEMBL4515950

N#Cc1cc(N)cc(Cl)c1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.42
ALDH1A1 P00352 5/20 0.42
THRB P10828 1/20 0.39
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
USP2 O75604 1/20 0.37
TRPV4 Q9HBA0 1/20 0.36
KHK P50053 1/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.34
CSNK1A1 P48729 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
TP53 P04637 2/20 0.33
MDM4 O15151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1810815 0.86 CYP3A4 (0.50) CYP3A4ALDH1A1THRBKDM4EMAPT
SCHEMBL2435542 0.80 CYP3A4 (0.56) CYP3A4ALDH1A1THRBKDM4EMAPT
SCHEMBL28338346 0.77 GPR35 (0.42) CYP3A4ALDH1A1KDM4EMAPTHPGD
SCHEMBL29739381 0.77 KDM4E (0.46) CYP3A4ALDH1A1THRBKDM4EMAPT
SCHEMBL28920176 0.77 CYP3A4 (0.41) CYP3A4ALDH1A1THRBMAPTHPGD
SCHEMBL1808542 0.77 TRPV4 (0.43) CYP3A4ALDH1A1THRBMAPTHPGD
SCHEMBL15277639 0.77 ALDH1A1 (0.41) CYP3A4ALDH1A1THRBKDM4EMAPT
SCHEMBL14744340 0.77 CYP3A4 (0.41) CYP3A4ALDH1A1THRBKDM4EMAPT
SCHEMBL16236615 0.77 KHK (0.43) CYP3A4ALDH1A1THRBKDM4EMAPT
SCHEMBL11808926 0.74 ALDH1A1 (0.37) CYP3A4ALDH1A1THRBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298894-A1 AMINO ACID COMPOUNDS ASAHI KASEI PHARMA CORPORATION (JP) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298894-A1 AMINO ACID COMPOUNDS S1PR1, S1PR2, S1PR5 CYP3A4 4658/4885ALDH1A1 2990/4885THRB 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.